Go to deals
Healthcare

Investmed Holdings Pty Limited has acquired 25% of Presmed Australia

Advanced Health Limited has sold 25% of its shares in Presmed Australia to Investmed Holdings Pty Limited.

Presmed Australia is the owner and operator of four day hospitals in Australia. Founded in 1997, it is one of the leading healthcare companies in Australia that specializes in the establishment and management of surgical day hospitals.

Investmed Holdings is an investment company formed by the management of Presmed Australia.

Advanced Health establishes, invests in and manages day hospitals. Its facilities are modern, compact and equipped to render same-day surgical procedures.

Oaklins’ team in South Africa acted as designated advisor to Advanced Health Limited.

Parties

Talk to the deal team

Annerie Britz

Senior Associate
Johannesburg, South Africa
Oaklins South Africa

Jean De Wet

Associate Director
Johannesburg, South Africa
Oaklins South Africa

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more